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Background: Early identiﬁ  cation of individuals at risk of developing persistent pain is important 
to decrease unnecessary treatment costs and disability. However there is scant comprehensive 
information readily available to assist clinicians to choose appropriate assessment instruments 
with sound psychometric and clinical properties.
Objective: A national insurer commissioned the development of a compendium of assessment 
instruments to identify adults with, or at-risk of developing, persistent pain. This paper reports 
on the instrument identiﬁ  cation and review process.
Methods: A comprehensive systematic literature review was undertaken of assessment instru-
ments for persistent pain of noncancer origin, and their developmental literature. Only assessment 
instruments which were developed for patients with pain, or tested on them, were included. 
A purpose-built ‘Ready Reckoner’ scored psychometric properties and clinical utility.
Results: One hundred sixteen potentially useful instruments were identiﬁ  ed, measuring severity, 
psychological, functional and/or quality of life constructs of persistent pain. Forty-ﬁ  ve instru-
ments were short-listed, with convincing psychometric properties and clinical utility. There were 
no standard tests for psychometric properties, and considerable overlap of instrument purpose, 
item construct, wording, and scoring.
Conclusion: No one assessment instrument captured all the constructs of persistent pain. While 
the compendium focuses clinicians’ choices, multiple instruments are required for comprehensive 
assessment of adults with persistent pain.
Keywords: persistent pain, assessment, psychometric properties, evidence-base, clinical 
utility
Background
An evidence-based practitioner integrates the best available research evidence with 
clinical judgment and patient preferences, when assessing and treating.1 Standardized 
assessment instruments are available for many health conditions. These initially served 
as checklists for health practitioners to consider essential elements in history taking.2 
Nowadays, they are used to predict disability, assess risk, and identify appropriate 
treatment strategies.2–4 A comprehensive health assessment should incorporate infor-
mation from relevant standardized instruments with a sound history, clinical tests and 
clinical judgment.1–4
This paper deals with assessment instruments for ‘persistent’, or ‘chronic pain’. 
Different health care providers use different philosophies and techniques when assess-
ing patients with extended pain histories.2–4 Siddall and Cousins5 deﬁ  ned ‘persistent 
(or extended) pain’ as “pain that exists beyond three months” (p. 511), a deﬁ  nition 
recently reiterated by Cousins.6 However Blyth, Cousins, and colleagues applied a 
similar deﬁ  nition to ‘chronic pain’.7–10 For this paper, we use the term ‘persistent pain’ 
to identify “pain that persisted beyond expected healing times.”
Inappropriate treatment for patients with persistent pain results in higher 
costs.9–11 There is convincing evidence that early identiﬁ  cation of patients at-risk of Journal of Pain Research 2009:2 22
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developing persistent pain reduces disability and increases 
return-to-work rates.9–14 This paper reports on a systematic 
literature review that identiﬁ  ed and critically appraised 
assessment instruments for persistent pain. The review was 
commissioned by the New Zealand Accident Compensa-
tion Corporation, New Zealand’s sole, 24-hour, no fault 
injury insurer and rehabilitation purchaser. This organiza-
tion is committed to providing health care providers with 
evidence-based resources. The outcome of this review was 
a compendium of high quality assessment instruments to 
assist health practitioners to identify patients with, or at risk 
of, persistent pain.
Methods
Project purpose
The systematic literature review identiﬁ  ed psychometrically 
sound, clinically-useful assessment instruments for 
persistent pain, for use by multidisciplinary health care 
teams, or individual practitioners, in face-to-face or 
telephone situations, and in different locations (large 
hospitals, rural practices, primary and secondary health care 
environments).
Reference group
An expert multidisciplinary reference group assisted the 
literature review team.
Search strategy
A comprehensive approach was taken to identify persistent 
pain assessment instruments (Appendix 1). The search 
identiﬁ  ed 1) any published questionnaire, survey, instru-
ment or rating scale developed primarily to assess 
persistent (noncancer) pain in adults, as well as instru-
ments which had been developed for other purposes, and 
subsequently tested on this patient group and 2) relevant 
peer-reviewed published background literature for each 
identiﬁ  ed instrument.
Background literature
Developmental literature reported the instrument’s 
psychometric properties. This usually reﬂ  ected results of 
psychometric testing, the instrument’s performance with 
different patient groups, and/or validation of instrument 
translation in other languages. Epidemiological literature 
reported threshold/cut points or population norms from 
population-application of the instrument.
Exclusion criteria
Instruments were excluded if they dealt with speciﬁ  c health 
conditions or body areas, were unavailable in English, 
were not fully described for clinical application, did not 
speciﬁ  cally assess noncancer persistent pain, and/or had no 
background literature.
Critical appraisal
Psychometric properties are reported and interpreted 
differently.2–4 Terminology differs depending on health disci-
pline, philosophy of pain mechanisms, the research paradigm 
used, the purpose of testing, and common usage. This review 
applied a published classiﬁ  cation of psychometric tests for 
consistency of interpretation.4
Project-speciﬁ  c scoring system
The lack of any published scoring system to rate the quality 
of assessment instruments for psychometric properties and 
clinical utility prompted the development of a purpose-built 
scoring system for this review (Ready Reckoner). This 
system gave equal weighting to 19 elements of psychometric 
properties and clinical utility (total score 19) (Figure 1), 
comprising:
•  Evidence of validity testing (face, content and construct 
validity, sensitivity, factor analysis)
•  Evidence of reliability testing (inter-tester, intra-tester, 
test–retest, internal consistency)
•  Availability of instructions for administration, and ease 
of literacy
•  Efficiency of administration using limited number 
of items
•  Capacity of manual score
• Efﬁ  cient (short) instrument administration time
•  Published thresholds/cut points, and/or normative values, 
speciﬁ  c (or able to be extrapolated) to New Zealand (NZ) 
persistent pain patients
•  Relevance to NZ clinical settings, and
•  No cost, and/or no professional membership, instrument 
registration or training requirements.
Instrument identiﬁ  cation, assessment, 
and short-listing
Step 1: Finding and collating instruments
A comprehensive list of potentially relevant assessment 
instruments was identiﬁ  ed from iterative searches of the 
literature following discussions between the project team 
and expert reference group.Journal of Pain Research 2009:2 23
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Coding
√ = yes
Validity Face √
Content √
Construct √
Comparison √
Sensitivity √
Factors √ (Number)
Reliability Inter-tester √
Intra-tester √
Test–retest √
Internal
Consistency √
Simple instructions, short, simply 
worded items √
<20 items √ (Number)
Able to be scored manually √
<15 minutes administration time
Population norms √
Cut off (threshold) scores √
Specific to NZ √
Instrument available at no cost √
Instrument available with no 
registration/limitations √
√ (Estimated 
administration time)
Figure 1 Ready Reckoner developed to review persistent pain assessment measures.
Step 2: Preparation for short-listing
The Step 1 instruments were reviewed and considered for 
short-listing (Step 3) if they met these conditions:
•  The instrument was primarily reported for assessment, 
rather than outcome measurement
•  At least four psychometric property measures were 
reported in background literature (reﬂ  ecting any testing 
for validity, reliability, sensitivity, factor analysis or 
comparison with other measures)4
•  The instrument authors could be contacted.
Step 3: Short-listing
The purpose, psychometric properties, and clinical utility of 
each instrument was critically considered using the reporting Journal of Pain Research 2009:2 24
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framework4 and the Ready Reckoner. Instruments which 
survived Step 3 were included in the compendium.
Results
Overview
Instrument classiﬁ  cation
Assessment instruments were classiﬁ  ed into the category 
that best described their purpose. These classifications 
were largely self-reported from the background literature, 
and comprised pain severity, psychological, functional, or 
multidimensional assessment of persistent pain, and general 
health status/quality of life.
Instrument inclusion
Step 1 identified 116 instruments from approximately 
350 publications (see row 1 of Table 1, and Appendix 2). 
In four instrument classiﬁ  cation categories, sub-groups of 
speciﬁ  c instrument purpose were identiﬁ  ed.
•  For pain severity assessment, there were three sub-groups 
(uni-dimensional; multidimensional; neuropathic; and 
nonneuropathic pain discrimination).
•  For psychological assessment, there were nine sub-groups 
(general psychological states; anxiety, depression and 
mood; physiological manifestations of anxiety and 
depression relative to persistent pain; pain cognition; 
catastrophizing, negative thoughts and fear; risk factor 
identiﬁ  cation; pain function; coping and management; 
and behavioral change readiness).
•  For functional assessment, there were six sub-groups 
(occupation focus; general function; interference 
[disability] in activities; impact on others; patient-speciﬁ  c 
instruments; and functional performance).
•  For multidimensional assessment of persistent pain, 
there were seven subgroups (occupational issues; 
expectations; yellow ﬂ  ags; pain dimensions; prediction 
of future disability; pain proﬁ  ling; outcome prediction 
instruments).
•  No sub-groups were identiﬁ  ed in the general health/
quality of life instruments, as all measured similar 
constructs.
Step 2 retained 59 instruments. Appendix 3 outlines the 
excluded instruments and the primary reason for exclusion. 
Step 3 short-listed 45 instruments. Reasons for short-listing 
(or excluding) instruments at this step are outlined in the 
‘Short-listing decisions’ section of this paper.
Table 1 outlines the review consort diagram. Instrument 
abbreviations are expanded in Appendix 2.
Psychometric properties
There was no consistency regarding research methods or 
statistics for psychometric testing. This constrained develop-
ment of a general picture of psychometric performance, and 
questioned whether one statistic was preferable to another, 
in demonstrating desirable characteristics of instrument 
performance. Table 2 reports the frequency of psychomet-
ric statistical tests, and their reported purpose, from Step 2 
(considering 59 instruments).
Short-listing decisions (Step 3)
Pain severity assessment instruments
Unidimensional scales
There is considerable detail regarding the psychometric 
properties of pain severity scales (Visual Analog Scale 
[VAS]/Verbal Rating Scale [VRS]/Numeric Rating Scale 
[NRS]).15,16 These instruments are useful for quick initial 
assessment of one pain dimension.
Multidimensional pain severity assessment instruments
The Chronic Pain Grade (CPG) scores the severity of 
persistent pain in three domains (characteristic pain intensity, 
disability, and persistence). The developmental literature17–21 
provides evidence of strong psychometric properties in terms 
of high intra-rater reliability, internal consistency for a range 
of health conditions and construct validity compared to other 
instruments. Normative data is available.
The McGill Pain Questionnaire (Long Form) 
(LF-MPQ) has strong psychometric properties and normative 
data.22 It includes a univariate pain scale (NRS). The instruc-
tions for completing the pain adjectives section are complex 
and it is recommended that they should be read to patients. 
There are several methods of scoring, and little information 
as to which is most appropriate. The McGill Pain Question-
naire (Short Form) (SF-MPQ)23 does not contain the long-
form body chart, and includes a VAS rather than an NRS. 
The short form version is less complex, quicker to administer 
and easier to score and interpret than the LF-MPQ. It covers 
the main elements of the LF-MPQ, and thus would appear 
to be preferable.
Distinguishing between neuropathic and 
nonneuropathic pain
Self-report and interview administration
The Douleur Neuropathique 4 Questions (DN4) is a 10-item 
instrument with high inter-rater reliability, high Kappa on 
retest, strong face validity and moderate correlation with 
health practitioners’ diagnosis.24–26 An interview contributes Journal of Pain Research 2009:2 25
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Table 2 Frequency of use, and purpose, of statistics to describe psychometric property
Test Purpose % Test Purpose %
 1. Cronbach’s  alpha Internal  consistency 56.4% 13. Face  validity 7.3%
 2. Student  t-test/ANOVA Responsiveness 38.2% 14. Kappa Internal  consistency 5.5%
  3.  Criterion validity Concurrent and predictive 32.7% 15. Wilcoxin rank test Responsiveness 3.6%
  4.  Construct validity Convergent and divergent validity 
OR ability to differentiate 
between groups
32.7% 16.   Spearman correlation 
coefﬁ  cient
Inter-rater reliability 1.8%
 5. Pearson  r Intra-rater reliability 20.0% 17.    Spearman correlation 
coefﬁ  cient
Test–retest 1.8%
 6.   Intra-class correlation 
coefﬁ  cient (ICC)
Intra-rater reliability 16.4% 18.  Percent agreement Inter-rater reliability 1.8%
  7.  Cut point Sensitivity and speciﬁ  city 16.4% 19.  Percent agreement Test-retest 1.8%
 8. Effect  size Responsiveness 14.5% 20. ICC Inter-rater  reliability 1.8%
 9. Pearson  r Test–retest 12.7% 21. ICC Internal  consistency 1.8%
10. Pearson  r Internal consistency 10.9% 22.  Pearson r Inter-rater reliability 0.0%
11.   Area under receiver operating 
characteristic (ROC) curve
Responsiveness 9.1% 23.   Spearman correlation 
coefﬁ  cient
Intra-rater reliability 0.0%
12. Kappa Test–retest 7.3% 24. Percent  agreement Intra-rater  reliability 0.0%
three items, using Yes/No responses, the remainder 
using a 0–100 scale. This instrument is appropriate for tele-
phone administration.
Self-report and consultation administration
The Leeds Assessment of Neuropathic Symptoms and Signs 
(LANSS) Pain Scale is a seven-item instrument which 
includes ﬁ  ve self-report items and two sensory tests.27 
The self-report questions use Yes/No responses, and the 
sensory testing requires the health practitioner to be with 
the patient for testing. Literature reports moderate Kappa 
test-retest scores and moderate Cronbach’s alpha for inter-
nal consistency.27–31 Its cut-point of 12 is sensitive (83%), 
and speciﬁ  c (87%) for differentiating between neuropathic 
and nonneuropathic pain.27 It assesses ﬁ  ve types of pain 
(thermal, dysesthesia, paroxysmal, evoked and autonomic 
dysfunction), and is appropriate to primary health care 
settings.
Self-report administration
The Neuropathic Questionnaire, Long Form (NPQ_LF) is 
a 12-item self-report instrument.32 The NPQ_LF has sound 
discriminant capacity between different pain-type groups.26 
Its cut-point of 0 is reported to be moderately sensitive 
(66.6%) and speciﬁ  c (74.4%).26 There is a short form of 
three items (NPQ_SF), reported to have similar psychometric 
properties and discriminant capacity.32
Table 3 reports the consistently high Ready Reckoner 
scores for the short-listed pain severity instruments with 
respect to psychometric properties and clinical utility.
Category 2: Psychological pain assessment instruments
The number and range of instruments in this category 
highlights the importance of considering the purpose, 
strengths and limitations of psychological assessment 
instruments prior to choosing the most appropriate 
one to use.
Anxiety, depression, and mood
The review found five relevant instruments measuring 
anxiety, depression and/or mood (Beck Depression 
Inventory [BDI], Kessler Psychological Distress Scale 
[K10], Hospital Anxiety and Depression Scale [HADS], 
Center for Epidemiologic Studies Depression Scale [CES-D], 
Zung Self-Rating Depression Scale [ZSRD]). Preference 
was given to clinically ﬂ  exible, multi-construct psycho-
logical instruments relevant to persistent pain, thus ZSRD 
(a generic measure of depression) was excluded from further 
consideration.
•  The BDI is a well established 21-item self-report rating 
inventory measuring characteristic attitudes and symp-
toms of depression and mood. It has high internal consis-
tency for both psychiatric and nonpsychiatric patients.33 
The BDI has comparable sensitivity and speciﬁ  city with 
CES-D for persistent pain patients.Journal of Pain Research 2009:2 27
Assessment instruments for patients with persistent pain
•  The K10 is a widely reported two-domain, 10-item 
measure of nonspeciﬁ  c psychological distress, pri-
marily intended as a measure of mood, anxiety, and 
depression.34 Its developmental literature reported 
high sensitivity and speciﬁ  city, internal consistency 
and intra-rater reliability. It has been used extensively 
in population surveys in Australia.35 The K10 is 
appropriate for primary health care settings, and for 
telephone delivery.
•  The CES-D is a 20-item measure of anxiety, depression, 
and depressed mood symptoms, with demonstrated 
sensitivity and responsiveness to change.36 It has been 
validated in different languages. It has shorter forms 
(CES-D-10 (10 item), Revised Form (eight item), Iowa 
Form (11 item) and Boston Form (10 item), however the 
original CES-D is the best researched.37,38
•  The HADS is a two-domain, 14-item measure designed 
to detect anxiety and depression, independent of somatic 
symptoms.39 The instrument has high internal consistency 
and strong correlations with quality of life measures 
(eg, Life Satisfaction Questionnaire). It has limited 
background literature for persistent pain patients. It 
has been validated in different languages. The HADS 
can only be used by psychologists with appropriate 
training.40
Physiological manifestations of anxiety and depression 
relative to persistent pain
The Modiﬁ  ed Somatic Perception Questionnaire (MSPQ) 
is a 13-item measure of heightened somatic and autonomic 
awareness related to anxiety and depression.41 It was devel-
oped to identify clinically signiﬁ  cant psychological distress 
in patients with persistent back pain. It has strong internal 
consistency, evidence of convergent and divergent validity 
with measures of anxiety and depression (eg, Minnesota 
Multiphasic Personality Inventory [MMPI], ZSRD, 
Table 3 Ready Reckoner for short-listed pain severity assessment measures
CPG DN4 LANSS MPQ_SF NPQ_LF NPQ_SF Unidimensional
Validity Face √√ √
Content √√
Construct √
Comparison √√ √ √ √ √
Sensitivity √√ √ √
Factors 291 0 6 6 1
Reliability Inter-tester √
Intra-tester √√
Test–retest √√ √ √ √ √
Internal 
Consistency
√
Simple instructions, short, simply 
worded items
√√ √ √
20 items √√√ √ √ √
•  Number of items 7 10 7 17 12 12 1
Able to be scored manually √√ √ √ √
15 minutes administration time √√√ √ √ √ √
•   Estimated average time to 
administer
15 10 10 15 10 10 2
Norms √√ √ √
Cut off scores √√√ √ √ √
Speciﬁ  c to NZ
No cost √√√ √ √ √ √
No registration/limitations √√√ √ √ √ √
Total √ 12 10 8 9 10 10 13
Abbreviations: CPG, Chronic Pain Grade; DN4, Douleur Neuropathique 4; LANSS, Leeds Assessment of Neuropathic Symptoms and Signs; MPQ_SF, McGill Pain Questionnaire 
Short Form; NPQ_LF, Neuropathic Pain Questionnaire Long Form; NPQ_SF, Neuropathic Pain Questionnaire Short Form.Journal of Pain Research 2009:2 28
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LF-MPQ) and significant discriminant validity within 
different groups of pain sufferers.41,42 It is one of the few 
instruments linking physical and psychological symptoms 
and thus adds important information to persistent pain 
assessments. It uses short wording which is appropriate for 
primary health care settings and telephone delivery.
Pain cognition and risk factor identiﬁ  cation
No instrument was retained for short-listing.
Catastrophizing, negative thoughts, fear
Three instruments were retained for short-listing.
•  The Fear Avoidance Beliefs Questionnaire (FABQ) is a 
16-item, short-worded, work-focused measure of patients’ 
beliefs about how physical activity and work affect their 
pain.43,44 The FABQ developmental literature reports 
high intra-tester reliability and test–retest, high internal 
consistency, and sound criterion and construct valid-
ity, tested against work time lost in the last 12 months, 
self-reported disability and poor behavioral performance. 
The FABQ is moderately correlated with the MSPQ, and 
highly correlated with the Tampa Scale for Kinesiophobia 
(TSK-11).43 It is appropriate for primary health care set-
tings and telephone delivery.
•  The TSK is available in long (17 items) and short 
(11 items) versions. Both instruments have similar high 
intra-rater reliability and internal consistency, and are sen-
sitive to differences between patients, and interventions.45 
The shorter version (TSK-11) is more relevant for primary 
health care assessment, and for telephone administration. 
The TSK has been validated in other languages.
•  The Pain Distress Inventory (PDI) measures pain-related 
interference with role functioning, using domains of 
family/home responsibilities, recreation, social activity, 
occupation, sexual behavior, self-care and life-support 
activity.46 It has sound internal consistency and content 
validity, and is sensitive to responses from different 
patient sub-groups. It correlates strongly with the 
Oswestry Disability Index and moderately with the BDI. 
The PDI is relevant to primary and secondary settings.
Behavioral change readiness
Four instruments were retained in this sub-group.
The Pain Behavior Checklist (PBC) is a 49-item, 
short-worded self-report about behaviors related to pain, 
assessing avoidance, complaint, and help-seeking.47 
The PBC has moderate evidence of intra-rater reliability, low 
correlations with measures of depression, good discriminant 
validity between different types of headache sufferers, 
and low correlations with measures of noise sensitivity.47 
Population norms reﬂ  ect 1. 5 standard deviations around 
the mean.47,48
The Chronic Pain Values Inventory (CPVI) is a patient-
centered six-domain instrument assessing family, intimate 
relations, friends, work, health, and growth or learning.49 
The CPVI is based on a values-based cognitive-behavioral 
approach to assessing persistent pain. The developmental 
literature reports strong correlations with other pain mea-
sures (Pain Anxiety Symptoms Scale [PASS], Chronic Pain 
Acceptance Questionnaire [CPAQ], work capacity, and 
medications), and signiﬁ  cant discriminant abilities.49 This 
instrument evaluates the discrepancy between importance 
and success in patient values related to functioning in differ-
ent environments (family, intimate relations, friends, work, 
health and growth and learning).
The Multidimensional Pain Readiness to Change 
Questionnaire (MPRCQ) scored highly on psychometric 
properties (convergent and discriminant validity, intra-rater 
reliability and internal consistency). However, the authors 
advised that at present, this instrument was available only 
for research purposes.50 It was thus excluded from further 
consideration for the compendium.
The Pain Self-Efﬁ  cacy Questionnaire (PSEQ) is a 10-item 
short-worded instrument which measures self-conﬁ  dence in 
performing functional and social activities, despite the pres-
ence of pain.51 The PSEQ is relevant to assess pain cognition 
in primary health care settings and can be administered by 
telephone. It has high intra-rater reliability, internal consis-
tency and stability over retest.
Pain function, coping and management
Twelve instruments (six sets of instruments) were short-
listed. Three measured persistent pain coping (Chronic Pain 
Coping Inventory [CPCI] suite of four instruments, Coping 
Strategies Questionnaire [CSQ] suite of four instruments, 
and the Pain Coping Inventory [PCI]). The other instruments 
comprised the CPAQ which measures acceptance of 
persistent pain, the Cognitive Risk Proﬁ  le for Pain (CRPP) 
which considers persistent pain management beliefs, and the 
Biobehavioral Pain Proﬁ  le (BPP) which measures reactions 
to persistent pain.
The CPCI suite (CPCI_65 [original], CPCI_partner, 
CPCI_42, CPCI_abbreviated) measures persistent pain 
coping strategies.52–54 The original CPCI includes domains 
of guarding, resting, asking for assistance, relaxation, 
task persistence, exercise/stretch, seek support, and Journal of Pain Research 2009:2 29
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coping self-statements. All versions of the CPCI demonstrate 
moderate to high internal consistency, and strong evidence 
of convergent, divergent and criterion validity tested within-
instrument domains, and with other instruments (eg, CES-D 
and Numerical Pain Rating Scale [NRS]). An advantage of 
this instrument is its ‘partner’ version, and the shorter ver-
sions which may be used for primary care assessment, or 
for retest. The instruments have relatively complex wording 
which may not be appropriate for people of low literacy. The 
instrument has been validated in other languages.
The CSQ suite assesses persistent pain coping.55,56 
It contains a long form (CSQ_LF of 50 items), a revised 
form (CSQ_R of 27 items) and an abbreviated 24 item form 
(CSQ-24). All forms have similarly strong internal consis-
tency, and strong concurrent and divergent validity with VAS 
and HADS. The CSQ_LF and the CSQ_R are wordy, thus they 
may not be suitable for some persistent pain patients with low 
literacy. Scoring instructions are published for the abbreviated 
version, which appeared most appropriate for clinical use.
The PCI is a multi-domain, simply-worded 33-item 
instrument which measures active and passive pain coping 
strategies using speciﬁ  c cognitive and behavioral strategies 
(pain transformation, distraction, reducing demands, retreat-
ing, worrying, and resting).57 It has moderate intra-rater 
reliability and internal consistency, strong inter-domain cor-
relation, and varying degrees of convergent and discriminant 
validity when compared with VAS, age, and illness states.
The CPAQ is a 20-item measure of pain acceptance.59 It has 
two domains that measure activity engagement (pursuit of life 
activities regardless of pain) and pain willingness (recognition 
that avoidance and control are often unworkable methods of 
dealing with persistent pain). Acceptance of persistent pain is 
believed to allow patients to focus on engaging in meaning-
ful and valued activities and goals. The CPAQ demonstrates 
moderate internal consistency, and divergent validity with the 
BDI.59 This instrument uses wordy items which may not be 
suitable for self-report from patients with low literacy.
Persistent pain management beliefs
Persistent pain management beliefs could be measured by 
the nine domain instrument CRPP, or the BPP.
The CRPP is a commercially available instrument which 
explores beliefs and attitudes that could interfere with pain 
management.60 The CRPP domains deal with philosophic 
beliefs about pain, denial that mood affects pain, denial that 
pain affects mood, perception of blame, inadequate support, 
disability entitlement, desire for medical breakthrough, 
scepticism of multidisciplinary approach and conviction of 
hopelessness. It has high internal consistency, and divergent 
validity with the PDI, CSQ, and MPQ.
The BPP is a composite measure of  behavioral, physiological, 
and cognitive reactions to pain.61 It has six domains of health 
care avoidance, physiological responsivity, thoughts of disease 
progression, environmental inﬂ  uences, past and current treat-
ment, and loss of control. The initial intent of the instrument 
was to use each patient’s answers to create a proﬁ  le that predicts 
what nondrug methods might work best for managing pain. In 
the developmental literature the BPP showed poor intra-rater 
reliability, high internal consistency, and divergent validity 
with the BDI and body consciousness.61 This instrument 
appears worded for patients of usual literacy levels.
Table 4 provides the Ready Reckoner scores for short-listed 
psychological persistent pain assessment instruments, and 
highlights their variable quality in terms of psychometric 
properties and clinical utility.
Category 3: Functional performance assessment 
instruments
A range of instruments which purported to measure function 
in persistent pain patients were considered for short-listing.
Instrument redundancy
The Work Limitations Questionnaire (WLQ) and the Work 
Limitations-26 (WL-26) were developed by the same group 
of researchers, and share over 90% items and wording.62,63 
The WLQ is a 25-item measure of on-the-job impact of per-
sistent health problems and/or treatment on work limitations 
(measuring capacity to work whilst workers are at work). 
The WLQ has four demand domains: physical, time, mental-
interpersonal and output. It has been tested using a two and 
four-week recall period. It scores each item using a ﬁ  ve-point 
Likert Scale: 0%, health makes the job demand difﬁ  cult none 
of the time; 25%, a little of the time; 50%, some of the time; 
75%, a great deal of the time; and 100%, health makes the job 
demand difﬁ  cult all of the time. The WLQ correlates well with 
adverse events in the workplace such as employee injuries and 
sick leave. The instrument has high internal consistency and 
moderate criterion and construct validity with the Short Form 
Health-36 Survey Questionnaire (SF-36). It is useful for self-
reporting. The WL-26 has 26-items of similar style, purpose 
and scoring to the WLQ. It deﬁ  nes the middle category on 
the Likert scale differently, as ‘approximately half the time’. 
Contact with the authors indicated that either instrument could 
be used to assess limitations in work functioning, however, 
they recommended the WLQ as the more robust measure. 
Both instruments require registration prior to use.Journal of Pain Research 2009:2 30
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Occupation focus
Two instruments (WLQ and Occupational Role Questionnaire 
[OccRQ]) were identiﬁ  ed, measuring different aspects of 
occupation. The OccRQ is an eight-item, two-domain instrument 
which tests attitudes to returning/remaining at work.64 It has 
two domains, assessing productivity and satisfaction. This 
instrument is suitable for self-report and administration in 
primary health care settings. The OccRQ has strong evidence 
of test-retest reliability and high internal consistency. It is 
moderately correlated with pain intensity (VAS).
General function
Three instruments were measures of general function, 
relevant in both primary and secondary health care settings: 
the 15-item Functional Abilities Conﬁ  dence Scale (FACS), 
the 12-item Resumption of Activities of Daily Living 
(RADL) scale and the seven-item PDI.
The FACS measures conﬁ  dence with general functional 
activities related to movements and postures affected by low 
back pain.65 The RADL measures self-reported resumption of 
usual daily activities estimating conﬁ  dence regarding return 
to usual activities.66 These instruments were developed by 
the same research group, are strongly correlated, and have 
high internal consistency.
The PDI estimates impact on everyday activities and 
relationships.67 It is a measure of pain-related interfer-
ence with role functioning, in domains of family/home 
responsibilities, recreation, social activity, occupation, sexual 
behavior, self-care and life-support activity. It is sensitive 
to responses from different patient groups, and correlates 
moderately with the BDI.
Patient-speciﬁ  c instruments
The importance of considering the patient’s perspective 
when measuring function was highlighted by Kliempt 
and colleagues.68 Two patient-speciﬁ  c instruments were 
identiﬁ  ed, both with strong psychometric properties and 
tested across health conditions.
The Patient Goal Priority Questionnaire (PGPQ) is a 
patient-speciﬁ  c measure of patients’ behavioral goals.69 
There are three measures: a questionnaire for assessing 
goals at baseline, a follow-up questionnaire, and a 
questionnaire for priority revision that can be used at any 
time after the commencement of treatment. The PGPQ 
can be used to identify and assess behavioral treatment 
goals, elaborate individual functional behavioral analyses 
relevant for everyday life functioning and determine the 
clinical signiﬁ  cance of treatment. It is negatively and 
moderately correlated with the PDI, and is not intended 
for group analyses.
The Patient-Specific Functional Scale (PSFS) is 
a patient-speciﬁ  c clinical tool for eliciting, measuring and 
recording patients’ descriptions of their disabilities.70 It has 
strong evidence of construct validity, intra-rater reliability, 
sensitivity and speciﬁ  city, and has an estimated amount of 
clinically signiﬁ  cant change.71,72
Interference (disability) in functional activities
Two instruments measured the extent of interference in 
usual function (measures of disability); the Functional 
Assessment Screening Questionnaire (FASQ) and the Brief 
Pain Inventory–Interference (BPI_I).
The FASQ is a simply-worded 15-item instrument.73 It 
had reports of high internal consistency, good ability to dif-
ferentiate between pain subgroups, and moderate divergence 
with pain intensity (VAS). No contact could be made with 
the developer, thus this instrument was excluded from con-
sideration.
The BPI_I is a 7-item derivative of BPI_long form 
(BPI_LF), which is considered in the next section.74 
The BPI_I measures interference in general activity, 
sleep, mood, and relationships. It can be quickly self- or 
interviewer-administered and is validated in other languages. 
Its wording may challenge patients of low-literacy. It has high 
internal consistency and moderate discriminant validity. The 
BPI_I has been modiﬁ  ed into a 12-item instrument, adding 
items relevant to disability (self care, recreation, social activi-
ties, ﬁ  nding out information and communication).75 The BPI 
suite requires registration prior to use.
Impact on others
Two instruments assessed the inﬂ  uence of pain, and people 
close to the patient. One instrument assessed the impact of 
the patient’s pain on others (Family Impact of Pain Scale 
[FIPS]), and the other assessed the impact of the spouse 
(‘signiﬁ  cant other’) on a patient’s pain responses (Spouse 
Response Inventory [SRI]).
The FIPS is a 10-item instrument measuring the extent 
to which family activities and interactions are affected by 
the patient’s persistent pain.76 It has two domains showing 
moderate test–retest and internal consistency. It is sensitive 
in identifying patients whose behavior signiﬁ  cantly impacts 
on family members. It moderately correlates with the VAS, 
the BDI, and the CSQ.
The SRI assesses the extent to which spouse responses 
contribute to a patient’s pain and disability.77 It has four Journal of Pain Research 2009:2 32
Grimmer-Somers et al
domains (solicitous and negative spouse response pain 
behaviors, and facilitating and negative spouse response well 
behaviors). It has moderate intra-rater reliability and poor to 
moderate construct validity with several other instruments 
(eg, PBC, VAS, BDI). The SRI requires registration with 
the author prior to use.
Functional performance
The Canadian Occupational Performance Measure (COPM) 
is a patient-centered measure of performance of activities 
and tasks of daily living.78–82 It is a semi-structured interview 
in which patients identify and rate areas of difﬁ  culty in 
occupational performance. It is a broad-ranging compre-
hensive instrument with strong evidence of construct and 
content validity, reliability in administration, test–retest, 
and correlation with other performance measures. It is 
a commercial product designed to be used by registered 
occupational therapists.
Table 5 reports the Ready Reckoner for the functional 
pain assessment instruments, highlighting their variable 
psychometric properties and clinical utility.
Category 4: Multidimensional pain assessment 
instruments
Exclusions
Two instruments were excluded on grounds of redundancy. 
The Dartmouth Pain Questionnaire (DPQ) is a ﬁ  ve-domain 
instrument adjunctive to the MPQ. It assesses the impact 
of pain on function.83 Other instruments measure this 
construct more comprehensively (eg, BPI). The BPI 
(32 items) and BPI_SF (15 items) are multidimensional 
psychometrically-sound measures of persistent pain features 
including pain severity, impact of pain on daily function, 
location of pain, pain medications and amount of pain relief in 
the past 24 hours or past week.74 The BPI has been validated 
in several languages. There is signiﬁ  cant overlap between 
Table 5 Ready Reckoner for the short-listed functional persistent pain assessment measures
BPI_I COPM FACS FIPS OccRQ PDI PGPQ PSFS RADL SRI WLQ
Validity Face √√ √
Content √√ √
Construct √√ √ √ √ √ √ √
Comparison √√ √ √ √ √ √ √√ √
Sensitivity √√ √√ √ √ √ √√
Factors 12 2 2 2 5 4
Reliability Inter-tester √√
Intra-tester √√ √ √ √√
Test–retest √√ √ √ √
Internal 
Consistency √√ √ √ √ √ √
Simple instructions, short, simply 
worded items
√√ √ √ √ √ √ √
20 items √√ √ √ √ √
•  Number of items 7 15 10 8 7 22 3 12 39 25
Able to be scored manually √√ √ √ √ √ √ √
15 minutes administration time √√ √ √ √ √ √ √ √
•  Estimated average time to administer 51 0 1 0 5 7 1 5 5 7 2 0 1 5
Norms √√ √ NA NA √
Cut off scores √√ √√ √ NA NA √√
Speciﬁ  c to NZ
No cost √√ √ √ √ √ √ √ √ √
No registration/limitations √√ √ √ √ √ √
Total √ 8 10 12 13 13 11 9 10 11 5 10
Abbreviations: BPI_I, Brief Pain Inventory-Interference; COPM, Canadian Occupational Performance Measure; FACS, Functional Abilities Conﬁ  dence Scale; FIPS, Family Impact 
of Pain Scale; OccRQ, Occupational Role Questionnaire; PDI, Pain Distress Inventory; PGPQ, Patient Goal Priority Questionnaire; PSFS, Patient-Speciﬁ  c Functional Scale; RADL, 
Resumption of Activities of Daily Living Scale; SRI, Spouse Response Inventory;   WLQ, Work Limitations-Questionnaire.Journal of Pain Research 2009:2 33
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BPI and BPI_SF items, and therefore the BPI_SF was 
short-listed. The BPI suite is free to use after registration.
The Work Disability Diagnosis Interview (WDDI) was 
excluded on the basis of complexity and administration 
time. It includes several standard assessment instruments, 
a physical examination and an interview.84 Its estimated 
completion time exceeds three hours, constraining its utility 
in most clinical settings. This instrument however offers a 
comprehensive approach to persistent pain assessment, and 
may be useful in multidimensional multidisciplinary special-
ized assessment settings.
Retained instruments
The Obstacles to Return-to-work Questionnaire (ObsRWQ) 
measures prognosis for return to work, pain intensity and 
depression.85 It is moderately sensitive and speciﬁ  c around 
a cut-point of 150. Part I assesses depression and pain 
intensity; Part II assesses six domains of difﬁ  culties at work 
return, physical workload and harmfulness, social support at 
work, worry due to sick leave, work satisfaction, and family 
situation and support; and Part III is a single scale dealing 
with perceived prognosis of work return. The items in Part I 
and some of the items in Part III are taken from the Örebro 
Musculoskeletal Pain Screening Questionnaire (ÖMPSQ). 
This instrument correlates moderately with BDI.
The ÖMPSQ, if applied 4–12 weeks after injury, identi-
ﬁ  es the likelihood that workers with soft tissue injury will 
develop long-term disability.86 This provides an early oppor-
tunity to intervene to reduce the risk of long term disability 
in injured workers. Speciﬁ  c to low back pain, the instrument 
has been tested in several settings, providing thresholds for 
predicting risk of long-term disability with moderate evi-
dence of validity.87–90
The West Haven–Yale Multidimensional Pain Inventory 
(WHYMPI) is a two-instrument suite (patient and ‘signiﬁ  -
cant other’ versions). The patient version has 52 items in 
12 domains divided into three parts, evaluating perceived 
interference of pain in occupational, social and family func-
tioning; perceptions of responses of others to the patient’s 
pain, and participation in common daily activities.91 There 
are extensive norms, and strong psychometric properties. 
The ‘signiﬁ  cant other’ version (WHYMPI_S) evaluates the 
inﬂ  uence of the patients’ pain on the partner/spouse, and 
partner inﬂ  uence on the patient.92 The WHYMPI requires 
registration prior to use.
Table 6 provides the Ready Reckoner for multidimen-
sional pain assessment instruments. The generally high 
scores for these instruments indicate their value for health 
practitioners, in using one instrument to assess a number of 
constructs related to persistent pain.
Category 5: Quality of life/general health 
assessment instruments
A number of instruments were identiﬁ  ed in this category, 
with different purposes in persistent pain assessment.
Exclusions
The EuroQol (EQ-5D), World Health Organization Quality 
of Life (WHOQOL; WHOQOL-Bref) and Quality of Well 
Being Scale (QWBS) instruments were developed speciﬁ  -
cally for population-health research and clinical trials.93–95 
They were not intended for clinical application, and were 
thus excluded from further consideration.
The remaining instruments are all commercial, and could 
be used for clinical assessments. Prior to the development 
of the SF-36, the Sickness Impact Proﬁ  le (SIP) was the best 
available quality-of-life measure.96 It assesses sleep and rest, 
eating, work, home management, recreation and pastimes, 
ambulation, mobility, body care and movement, social 
interaction, alertness behavior and communication. These 
domains can be aggregated into broader physical and psycho-
social domains. As it has now largely been superseded by the 
SF-36, the SIP was excluded from consideration. The Health 
Status Questionnaire (HSQ 2.0) contains the same items and 
domains as the SF-36, relevant to persistent pain.97 Given the 
lack of normative data, and overlap with the SF-36, the HSQ 
was also excluded from further consideration.
Retained instruments
The SF-36 contains eight domains (physical functioning, 
role limitations due to physical problems, bodily pain, social 
functioning, mental health, role limitations due to emotional 
problems, vitality, and overall/general health).98 International 
population and health condition norms are reported.99 Given 
its normative data, the large number of publications which 
report use of the SF-36, and its wide use in clinical and 
research environments, it was short-listed.
The Nottingham Health Proﬁ  le (NHP) measures pain 
intensity, and impact of pain on general life areas.100 It 
has strong evidence of reliability, validity, sensitivity to 
change and domain construction (physical activities, pain, 
sleep, social isolation, emotional reactions, energy level, 
and whether their present level of health affects their life in 
occupation, personal relationships, hobbies etc). In a publica-
tion which compared the NHP and SF-36 for patients with 
lower limb ischaemia,101 the NHP was more sensitive in 
discriminating between ischemia levels. This highlights the Journal of Pain Research 2009:2 34
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importance of considering the sensitivity of any instrument 
for patients with different types of persistent pain.
Table 7 provides the Ready Reckoner scores for the gen-
eral health/quality of life assessment instruments.
Discussion
This review identiﬁ  ed many assessment instruments pub-
lished over the past 20 years, dealing with many constructs 
related to persistent pain presentations and behaviors. Only a 
few instruments were speciﬁ  c to single health disciplines, or 
single persistent pain constructs. The publication of assess-
ment instruments appears to mirror developments in under-
standing persistent pain behaviors and presentations, in terms 
of neuroanatomy, biology, physiology, psychology, and social 
science.5–14 However, no one instrument currently appears 
to assess all features of persistent pain, and thus multiple 
instruments are required to provide a comprehensive descrip-
tion of an individual with persistent pain. This is perhaps 
not surprising, as given the variability in etiology, location 
and nature of persistent pain presentations, and the variable 
individual time taken for such pain to develop, it would be 
a challenge to develop one instrument which addressed all 
aspects of persistent pain for all patients.6–10 Given the time 
required to administer even the shortest instrument in every 
assessment category identiﬁ  ed in this review, this could be 
daunting and burdensome for patients and health providers. 
Thus, health practitioners using persistent pain assessment 
instruments for the ﬁ  rst time would be advised to start with a 
multidimensional instrument which provides an overview of 
the patient. Once core areas of concern have been identiﬁ  ed, 
more speciﬁ  c assessment instruments could be used.
There was considerable overlap in item intent and 
wording within- and between-persistent pain assess-
ment categories in the short-listed instruments. It appears 
that instruments measuring similar constructs have been 
developed by different research groups with apparently 
little reﬂ  ection on already published instruments. Choosing 
between similarly worded and constructed instruments with 
similar purposes, and similar psychometric properties, thus 
provides a challenge for health practitioners. The review 
Table 6 Ready Reckoner for the short-listed multidimensional persistent pain assessment measures
BPI_SF* GPQ OccRQ ÖMPSQ WHYMPI WHYMPI_S
Validity Face √√ √ √√ √
Content √√
Construct √√ √ √√ √
Comparison √√ √ √
Sensitivity √√ √ √√ √
Factors 25 9 3 3
Reliability Inter-tester √√ √
Intra-tester √√ √ √
Test–retest √√ √√ √
Internal √
Consistency √√ √ √ √
Simple instructions, short, simply worded items √√ √ √√ √
20 items √
•  Number of items 15 24 55 56 52 52
Able to be scored manually √√ √ √ √
15 minutes administration time √√
•  Estimated average time to administer 10 12 20 20 20 20
Norms √√ √√
Cut off scores √√ √ √√ √
Speciﬁ  c to NZ √
No cost √√ √ √√ √
No registration/limitations √√ √ √ √
Total √ 14 12 12 14 13 13
Abbreviations: BPI_SF, Brief Pain Inventory; GPQ, Glasgow Pain Questionnaire; OccRQ, Occupational Role Questionnaire; ÖMPSQ, Örebro Musculoskeletal Pain Screening 
Questionnaire;   WHYMPI, WHYMPI_S, West Haven-Yale Multidimensional Pain Inventory.Journal of Pain Research 2009:2 35
Assessment instruments for patients with persistent pain
Table 7 Ready Reckoner for the short-listed general health/quality 
of life persistent pain assessment measures
NHP SF-36
Validity Face √√
Content √√
Construct √√
Comparison √√
Sensitivity √√
Factors 59
Reliability Inter-tester √√
Intra-tester √√
Test–retest √√
Internal 
Consistency √√
Simple instructions, short, simply 
worded items
√√
20 items
Number of items 38 36
Able to be scored manually
15 minutes administration time √
Estimated average time to administer 10 20
Norms √√
Cut off scores
Speciﬁ  c to NZ √
No cost
No registration/limitations
Total score 12 12
Abbreviations: NHP, Nothngham Health Proﬁ  le; SF-36, Short Form Health Survey-36.
highlighted how some instruments changed over time, with 
little explanation of wording change, change in item order, 
or addition or removal of items. This suggests an opportunity 
for international research groups to collaborate on collating, 
critically appraising and then distilling essential items from 
key instruments, in order to develop a comprehensive battery 
of assessment questions which would address all aspects of 
persistent pain presentation.
The generalizability of many instruments was constrained 
by the size of study samples, and/or the speciﬁ  c nature 
of populations on which instruments were tested. This 
reduced the usefulness of many instrument’s population 
norms, or cut-points, and raised concerns that if these 
were inappropriately applied, patients may be inaccurately 
classiﬁ  ed regarding persistent pain behaviors. This highlights 
the need for instrument developers to research their instru-
ment’s performance in different patient subgroups, with 
different demographic characteristics and health conditions. 
This review also flagged the importance of improved 
understanding of the social and cultural implications of 
describing pain experiences, to test the stability and gener-
alizability of persistent pain descriptors across population 
groups and settings.
There was little consistency in choices of statistics tests 
for psychometric properties, or ways in which psychometric 
properties were reported. This meant that, despite the vol-
ume of published research in this area, little information was 
presented in useful terms to encourage clinical uptake of any 
persistent pain assessment instrument. Thus for many health 
practitioners, the wealth and variability of published material 
on persistent pain assessment may be overwhelming with 
respect to instrument choice. For instance, there was little 
convincing evidence to support the use of many long versus 
short/revised instruments, in terms of psychometric properties. 
Choice would appear to be based on personal preference, and/
or clinical imperatives. This ﬁ  nding highlights the need for 
developers of new instruments to justify item intent, number, 
and wording, and to provide evidence of psychometric proper-
ties to convince users that their instrument provides the most 
useful assessment information in speciﬁ  c circumstances.
Fewer than 25% of instruments initially identiﬁ  ed in the 
literature search were short-listed. The short-listing process 
relied on the quality of background literature reporting. 
Had more detail been available on psychometric proper-
ties or clinical utility, other instruments may have been 
short-listed. Some instruments, whilst appearing promising, 
reported psychometric properties in unpublished conference 
proceedings or research theses. As these were often not avail-
able via library databases, the instrument was excluded in line 
with the review criteria. Some instruments showed promise 
on initial test results published in one or two research papers, 
however there was little subsequent research to support its 
use. On the other hand, some instruments with less robust 
psychometric properties were regularly reported as research 
tools, and would be thus more familiar to health practitioners. 
Most instrument developers could be contacted, and many 
willingly provided additional (although often unpublished) 
details on their instrument’s performance.
The Ready Reckoner, although unvalidated, provided 
a comprehensive way of collating key information on 
psychometric properties and clinical utility for efﬁ  cient clinical 
decision-making. It highlighted that many instruments did not 
have good clinical utility despite having sound psychometric 
properties. Clinical utility could be constrained by lengthy or 
unwieldy questions, complex wording, or multiple intentions 
in one question. Administration time for such instruments Journal of Pain Research 2009:2 36
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often precluded their ready clinical use. This review sought 
to identify instruments relevant to primary health care set-
tings. These were generally short, efﬁ  cient to deliver and 
score and sensitive to persistent pain problems. A resource 
of high quality instruments for primary care providers should 
increase the frequency with which persistent pain patients are 
identiﬁ  ed early.
The importance of considering the patient in an holistic 
manner was supported not only by the different categories 
of persistent pain assessment, but also by the availability of 
assessment instruments for ‘signiﬁ  cant others’. These instru-
ments recognize that patients with persistent pain rarely exist 
in isolation, and that their pain behaviors have an effect on, 
and are inﬂ  uenced by, the behaviors of people around them.
Conclusion
Early identification of patients at-risk of developing 
persistent pain is essential to ensure appropriate and timely 
intervention, and reduce avoidable individual, social, 
community and work-related costs. No one assessment 
instrument captured all the constructs of persistent pain. 
While the compendium focuses clinicians’ choices on high 
quality, clinically useful instruments, clinicians should use 
multiple instruments to ensure comprehensive assessment 
of adults with persistent pain.
The compendium is available from New Zealand Accident 
Compensation Corporation. Health practitioners who have 
not, to date, used standard assessment instruments for 
persistent pain patients are encouraged to choose instruments 
from those provided in the compendium.
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Appendix 1
Search strategy
The search strategy incorporated all possible variations of 
nomenclature relating to persistent pain assessment. The 
search sought to identify:
•  all questionnaires, surveys, instruments and rating scales 
developed to assess persistent pain in adults who had 
noncancer pain, and
•  developmental literature including psychometric testing 
of these instruments.
Concurrently, background literature was sought on:
•  biomedical, functional, behavioral, and psychosocial 
aspects relevant to persistent pain assessment
•  risk factors for developing persistent (noncancer) pain
•  special populations (indigenous, rural, and remote) and 
instruments speciﬁ  cally developed to address their needs, 
and
•  different methods of administration of assessment instru-
ments (in person, via telephone or mail).
Search terms
MeSH subject headings: pain measurement, persistent pain, 
questionnaires, indigenous population
Non-MeSH search terms: tool*, scale*, inventor*, 
questionnaire*, protocol*, survey*, proﬁ  le*, model*, drawing*, 
checklist*, index, pain, pain assessment, persist*, functional, 
biomedical, psychosocial, psycholog*, behaviour*, behavior*, 
risk, assess*, screen*, rural, indigenous, maori, postal, telephone, 
psychometric, valid, reliab*, respons*. The search terms and 
strategies were amended as required for other databases.
Library databases and internet sites
All available databases were accessed through university 
library sources. The ‘parent’ data bases sourced mainstream 
academic databases which list the peer reviewed literature, 
including OVID (AMED, CINAHL, MEDLINE, EMBASE) 
and INFORMIT (AUSThealth, INFORMIT Plus Text [Medi-
text], INFORMIT e-library). These principal databases were 
interrogated ﬁ  rst and publications sourced from these data-
bases contributed more than 95% of the literature reviewed. 
To ensure rigor in searching of literature, other secondary 
databases to validate the initial ﬁ  ndings were then searched, 
including, but not limited to, PsychINFO, PsycARTICLES, 
Science Direct, Web of Science, PubMed, etc. Interroga-
tion of these databases revealed mostly redundant duplicate 
publications, already identiﬁ  ed from the larger databases.Journal of Pain Research 2009:2 41
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Appendix 2 
Persistent pain severity 
Psychological assessment of chronic pain
Unidimensional measure of pain severity  Visual Analogue Scale (VAS) [10 cm line] (reported,22 
discriminant values102
Verbal Rating Scale (VRS) [word descriptors]15
Numeric Rating Scale (NRS) [0–10 categories]15
Multidimensional pain assessment instruments Chronic Pain Grade (CPG)17 
McGill Pain Questionnaire Long form (MPQ_LF)22
McGill Pain Questionnaire Short form (MPQ_SF)23
Neuropathic Pain Scale (NPS)103 
Neuropathic Pain Symptom Inventory (NPSI)104
Discriminating neuropathic and nonneuropathic pain Douleur Neuropathique 4 (DN4)25
IDPain105
Leeds Assessment of Neuropathic Symptoms and Signs 
(LANSS)27 (PHC)
Neuropathic Pain Questionnaire Long Form (NPQ_LF)106 
Neuropathic Pain Questionnaire Short Form (NPQ_SF)106 
Psychological states not 
directly related to persistent pain 
Depression, Anxiety, and Positive Outlook (DAPOS)107 
Measurement of anxiety, depression, and mood  Beck Depression Inventory (BDI)108 (peer reviewer)
Center for Epidemiologic Studies-Depression Scale 
(CES-D)36 
Hospital Anxiety and Depression Scale (HADS)109 
(ACC Pain Focus Group)
Kessler Psychological Distress Scale (K10)34 
Zung Self-Rating Depression Scale (ZSRD)110
Physiological manifestations of anxiety and 
depression relative to persistent pain
Modiﬁ  ed Somatic Perception Questionnaire (MSPQ)41 
Pain cognition Cognitive Coping Strategies Inventory-Revised 
(CCSI-R)111 
Pain Anxiety Symptoms Scale (PASS-SF(20), PASS-40, 
PASS-72)112 
Pain Cognition List (PCL)113
Pain Cognitions Questionnaire (PCQ)114
Catastrophizing, negative thoughts, fear Negative thoughts about pain 
Inventory of Negative Thoughts in Response to Pain 
(INTRP)115
Catastrophizing 
Pain Catastrophizing Scale (PCS) (includes a scale for the 
signiﬁ  cant other/partner PCS_S)116Journal of Pain Research 2009:2 42
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Persistent pain fear 
  1. Fear-Avoidance Beliefs Questionnaire (FABQ)43
  2. Fear Avoidance of Pain Scale (FAPS)117
  3. Fear of Pain Comparisons (FPC_11)118
  4. Tampa Scale for Kinesiophobia (TSK)119
  5.   Tampa Scale for Kinesiophobia Short version 
(TSK-11)45
Pain distress 
Pain Distress Inventory (PDI)46
Vigilance, preoccupation, and awareness of pain 
Pain Vigilance and Awareness Questionnaire (PVAQ)120
Psychopathology in persistent pain 
Symptoms of Chronic Pain List (SCL_27)121
Risk factor identiﬁ  cation Distress and Risk Assessment Method (DRAM)122
Pain function, coping & management Ability to function with persistent pain
Pain and Impairment Relationship Scale (PAIRS)123
Persistent pain coping
1.   Chronic Pain Coping Inventory suite 
(CPCI_65 (CPCI_signiﬁ  cant other, CPCI_42,
and CPCI_abbreviated)52 
2.   Coping Strategies Questionnaire (CSQ_50)124 which 
also includes a revised (CSQ_R(27)), a shorter version 
(CSQ24)56 (and an abbreviated version 
(CSQ_abbreviated)54
3.   Stoicism (Pain Attitudes Questionnaire-Revised (PAQ-
R))125 Pain-Coping Inventory (PCI)57
4. Pain Coping Style Inventory (PCSI)126 
5.   Vanderbilt Multidimensional Pain Management Inven-
tory (VMDPMI)127
Acceptance of persistent pain 
Chronic Pain Acceptance Questionnaire (CPAQ)128
Persistent pain management beliefs
Cognitive Risk Proﬁ  le for Pain (CRPP)60
Reactions to persistent pain
1. Brief Pain Coping Inventory (BPCI)129
2. Biobehavioral Pain Proﬁ  le (BPP)61
Pain attitudes 
Survey of Pain Attitudes (SOPA_57),130 which includes a 
35 item version (SOPA_35) and a short version 
(SOPA_S)
Pain beliefs and consequences 
Pain Beliefs Questionnaire (PBQ)131
Pain beliefs and knowledge Journal of Pain Research 2009:2 43
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Pain Beliefs and Perceptions Inventory (PBPI)132
Psychological pain functioning 
1.   Multidimensional Locus of Pain Control Questionnaire 
(MLPC)133 
2.   Pain Solutions Questionnaire (PaSolQ)134
3. Pain Patient Proﬁ  le (PPP)135
Behavioral change readiness Chronic pain self-efﬁ  cacy scale (CPS-ES)136
Chronic Pain Values Inventory (CPVI)49
Multidimensional Pain Readiness to Change 
Questionnaire (MPRCQ)50 
Pain Behavior Checklist (PBC)137
Pain Stages of Change Questionnaire (PSCQ)138
Pain Self Efﬁ  cacy Questionnaire (PSEQ)139
Eighteen instrument suites (25 instruments) were identiﬁ  ed, these being BDI, BPP, CES-D, CPAQ, CPCI suite of four 
instruments, CPVI, CRPP, CSQ suite of four instruments, FABQ, HADS, K10, MPRCQ, MSPQ, PBC, PCI, PSEQ, TSK 
suite of 2 instruments, ZSRD. 
Functional capacity
Occupation focus Work Limitations Questionnaire suite (WLQ)62
Work Limitations-26 (WL-26)140 
Occupational Role Questionnaire (OccRQ)64 
Risk Factor Questionnaire (RFQ)141
General function (women only) Inventory of Functional Status – chronic pain (IFS-CP)142
General function Functional Abilities Conﬁ  dence Scale (FACS)65
Resumption of Activities of Daily Living Scale (RADL)66
General function (Indigenous health) Kempsey Survey of Muscle, Joint and Bone Conditions 
(KSMBJC)143
Interference (disability) in functional activities Brief Pain Inventory-Interference (BPI_I)144 (7-item deriva-
tive of BPI_LF,74 developed into a 12-item instrument75 for 
disabled persons)
Functional Assessment Screening Questionnaire 
(FASQ)73
Functional Interference Estimate (FIE)145 
Pain Disability Index (PDI)146
Pain Disability Questionnaire (PDQ)147
Impact on others Family Impact of Pain Scale (FIPS)76
Spouse Response Inventory (SRI)148
Patient-speciﬁ  c instruments Patient Goal Priority Questionnaire (PGPQ)69 
Patient-Speciﬁ  c Functional Scale (PSFS)70 
Performance Canadian Occupational Performance Measure (COPM)78 Journal of Pain Research 2009:2 44
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Multidimensional assessment of persistent pain
Occupational issues Obstacles to Return-to-Work Questionnaire (ObsRWQ)85
Expectations  Patient Centered Outcomes Questionnaire (PCOQ)149
Medical Rehabilitation Follow Along measure 
(MRFA) – Musculoskeletal form150
Yellow ﬂ  ags Örebro Musculoskeletal Pain Screening Questionnaire 
(ÖMPSQ). This uses exactly the same wording as the Acute 
Low Back Screening Questionnaire (Yellow Flags) already 
in use by ACC in the Acute Low Back Pain guidelines.151 
The ÖMPSQ includes a wide range of body parts likely to 
be affected by musculoskeletal pain.
Obstacles to Return-to-Work Questionnaire (ObsRWQ) 
(listed above)85 contains items relating to depression 
Pain dimensions Brief Pain Inventory (BPI)144 (original (also known as the 
long form))
Brief Pain Inventory (BPI-SF)144 (short form)
Glasgow Pain Questionnaire (GPQ)152
Health Background Questionnaire for Pain (HBQP)153
Hunter Integrated Pain Service (HIPS) Patient Screening 
Questionnaire (HIPSPSQ) (no published reference)154
Obstacles to Return-to-Work Questionnaire (ObsRWQ)85 
(listed above and reporting pain experiences).
Pain Outcomes Questionnaire suite of six instruments 
(POQ) Intake and Pain Outcomes Questionnaire-Short Form 
(POQ-42, POQ-SF, POQ-DC-28 [discharged from acute 
care], POQ-FU-34 [at follow-up], POQ-DC-5 [satisfaction 
scale extracted from POQ-DC-28])155
West Haven-Yale Multidimensional Pain Inventory 
(WHYMPI)91 including the WHYMPI_S (Signiﬁ  cant Other 
Instrument)
Prediction of future disability (LBP only) Vermont Disability Prediction Questionnaire (VDPQ)156
Pain proﬁ  ling and outcome prediction instruments Proﬁ  le of Chronic Pain: Screen (PCP:S)157
Proﬁ  le of Chronic Pain: Extended Assessment Battery 
(PCP:ES)158
Pain Outcomes Proﬁ  le (POP)155
Compilation or adaptation of existing instruments Dartmouth Pain Questionnaire (DPQ) (enhancing items 
from McGill Pain Questionnaire [MPQ])83
Work Disability Diagnosis Interview (WDDI)84 involves 
interview which consists partly of questions compiled by 
instrument authors and partly of a range of standardised 
questionnaires such as the Oswestry Disability Index, 
Fear-Avoidance Beliefs Questionnaire and Work APGAR.Journal of Pain Research 2009:2 45
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General health/Quality of life assessment
EuroQol (EQ-5D)93
Health Status Questionnaire 2.0 (HSQ)159
Nottingham Health Proﬁ  le (NHP)160
Quality of Well-Being Scale – Self-Administered (QWBS)95
World Health Organization Quality of Life (WHOQOL)94 (including a short form WHOQOL-Bref)
Short Form-36 Health Survey (SF36)98
Sickness Impact Proﬁ  le (SIP)96Journal of Pain Research 2009:2 46
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Appendix 3 
Excluded instruments
Persistent pain severity
Lack of published literature: At the time of the review, there 
was no published literature on psychometric properties of the 
instrument IDPain, and this instrument was excluded from 
further consideration. 
Contact with author: Despite repeated attempts, no contact 
was able to be made with the author of the NPS (Galer) 
and thus this instrument was excluded after psychometric 
property evaluation. 
Primary function: The NPSI is mainly reported in 
the literature as an outcome measure, not an assess-
ment instrument, and it was thus excluded from further 
consideration. 
Psychological assessment
of persistent pain
Twenty-six instrument suites (31 instruments) were excluded 
during Step 2. The instruments, and primary reasons for 
exclusion, are listed below. 
 1. Brief Pain Coping Inventory (BPCI) no information on 
administration or scoring
  2. Cognitive Coping Strategies Inventory-Revised (CCSI-R) 
no psychometric properties 
 3. Chronic Pain Self-Efficacy Scale (CPS-ES) limited 
evidence of strong psychometric properties
 4. Depression, Anxiety and Positive Outlook (DAPOS) 
limited evidence of strong psychometric properties
 5. Distress and Risk Assessment Method (DRAM) 
replicates questions in MSPQ and Zung instruments, 
minimum psychometric properties
  6. Fear Avoidance of Pain Scale (FAPS) No information on 
psychometric properties
 7. Fear of Pain Comparisons (FPC) uncertain clinical 
utility161. Found it was less useful than the PASS and 
FABQ for understanding chronic pain
 8. Inventory of Negative Thoughts in Response to Pain 
(INTRP) limited evidence of strong psychometric 
properties
 9. Multidimensional Locus of Pain Control Question-
naire (MLPC) authors stated that further work is 
required on the instrument’s psychometric properties, 
particularly aspects of validity. The PSCQ covers this 
area better. 
10. Pain and Impairment Relationship Scale (PAIRS) limited 
evidence of strong psychometric properties
11. Pain Attitudes Questionnaire-Revised (PAQ-R) limited 
evidence of strong psychometric properties
12. Pain Solutions Questionnaire (PaSolQ) validity untested 
in English language
13. Pain Anxiety Symptoms Scale (PASS-20, PASS-40, 
PASS-72) limited evidence of strong psychometric 
properties, wordy instrument with multiple items in the 
long forms, uncertain psychometric properties in the 
short form 
14. Pain Beliefs and Perceptions Inventory (PBPI) limited 
evidence of strong psychometric properties
15. Pain Beliefs Questionnaire (PBQ) unable to trace 
authors, minimum evidence of psychometric properties
16. Pain  Cognition  List  (PCL) limited evidence of strong 
psychometric properties, scoring instructions only 
available in Dutch
17. Pain Cognitions Questionnaire (PCQ) unable to trace the 
authors
18.  Pain Catastrophizing Scale (PCS) limited evidence of 
strong psychometric properties
19. Pain Coping Style Inventory (PCSI) uses AVAS for 
scoring all items, minimum psychometric properties, 
replicates other more readily scored instruments
20. Pain Distress Inventory (PDI) could not contact developers
21. Pain Patient Proﬁ  le (PPP) limited information on psycho-
metric testing
22.  Pain Stages of Change Questionnaire (PSCQ) limited 
evidence of strong psychometric properties
23. Pain Vigilance and Awareness Questionnaire (PVAQ) 
limited evidence of strong psychometric properties
24. Symptoms of Chronic Pain List (SCL_27) limited 
evidence of strong psychometric properties
25. Survey of Pain Attitudes (SOPA) (including SOPA_35, 
SOPA_57, SOPA_short) limited evidence of strong 
psychometric properties
26. Vanderbilt Multidimensional Pain Management Inventory 
(VMDPMI) limited access to background documentation, 
limited evidence of psychometric properties, overlaps 
with other better credentialed instruments 
Functional assessment of persistent pain
The excluded instruments during Step 2 comprised FIE, 
IFS_CP, KSMBJC, PDQ, RFQ (all for poor evidence of 
psychometric testing). Journal of Pain Research 2009:2 47
Assessment instruments for patients with persistent pain
Multidimensional assessment
of persistent pain
Six instruments (one instrument suite) were excluded 
because the primary function was to measure outcome (POQ 
suite). Eight instruments were excluded during Step 2 for 
poor evidence of psychometric testing, comprising HBQP, 
HIPSPSQ, MRFA, PCOQ, PCP_Screen, PCO_Ext, POP 
and VDPQ. 
General health/Quality of life assessment 
of persistent pain
No instruments were excluded during Step 2. 